This proposal represents a continuing effort by our laboratory to understand the mechanism of protein-mediated sugar transport across cell membranes. The broad goal of this proposal is to understand how sugar transport protein oligomerization occurs and how transport protein oligomerization affects transport function. These studies will assist in our long term goals of understanding the physical basis and the cellular regulation of sugar transport and could ultimately be of value in the management of disordered states such as diabetes. Our studies show that the human erythrocyte sugar transport system exists in two catalytically active forms: as a tetramer (major species) and as a dimer (minor species) of GLUT1 proteins. The oligomeric state of the sugar transport protein determines the catalytic properties of transport.
Specific Aim 1 asks whether purified tetrameric GLUT1, like erythrocyte-resident GLUT1, is a multisite, allosteric transporter. Our studies suggest that the arrangement of substrate binding sites in tetrameric and dimeric GLUT1 is different. Tetrameric GLUT1 appears to behave as 2 """"""""two-site carriers"""""""" that simultaneously expose both sugar influx and sugar efflux sites to substrate. Dimeric GLUT1 behaves as 2 independent """"""""simple carriers"""""""" that alternately expose sugar influx and sugar efflux sites to substrate. We test this hypothesis by asking whether purified, tetrameric or dimeric GLUT1 can bind substrates at sugar influx and at sugar efflux sites simultaneously. If our hypothesis is correct, only the tetramer should expose both sites simultaneously.
Specific Aim 2 asks if the cryptic cysteines in tetrameric GLUT1 are present as disulfides. Tetrameric GLUT1 contains only 2 free cysteines per GLUT1 monomer, is converted to dimer by reductant but is not two disulfide-linked dimers. Dimeric GLUT1 contains 6 free cysteines per GLUT1 monomer. We use differential carboxymethylation procedures and peptide mapping to identify the cryptic cysteines of the tetramer and to determine whether the cryptic cysteines are internal disulfides, mixed disulfides or are fatty acylated.
Specific Aim 3 asks what role the cryptic cysteines of tetrameric GLUT1 play in tetramerization of GLUT1. If modification of a specific cysteine causes tetramerization of GLUT I, deletion of the cysteine should prevent tetramer formation. Each of the 6 GLUT1 cysteines will be mutated. The effects of these mutations on GLUT1 oligomeric structure, ligand binding and sugar transport will be evaluated. If successful, these studies will greatly assist in our long term goal of understanding sequence-specific determinants of sugar transporter higher order structure and function.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK044888-03
Application #
2144151
Study Section
Metabolism Study Section (MET)
Project Start
1992-05-01
Project End
1996-05-31
Budget Start
1994-05-01
Budget End
1996-05-31
Support Year
3
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Biochemistry
Type
Schools of Medicine
DUNS #
660735098
City
Worcester
State
MA
Country
United States
Zip Code
01655
Ojelabi, Ogooluwa A; Lloyd, Kenneth P; De Zutter, Julie K et al. (2018) Red wine and green tea flavonoids are cis-allosteric activators and competitive inhibitors of glucose transporter 1 (GLUT1)-mediated sugar uptake. J Biol Chem 293:19823-19834
Lloyd, Kenneth P; Ojelabi, Ogooluwa A; Simon, Andrew H et al. (2018) Kinetic Basis of Cis- and Trans-Allostery in GLUT1-Mediated Sugar Transport. J Membr Biol 251:131-152
Lloyd, Kenneth P; Ojelabi, Ogooluwa A; De Zutter, Julie K et al. (2017) Reconciling contradictory findings: Glucose transporter 1 (GLUT1) functions as an oligomer of allosteric, alternating access transporters. J Biol Chem 292:21035-21046
Ojelabi, Ogooluwa A; Lloyd, Kenneth P; Simon, Andrew H et al. (2016) WZB117 (2-Fluoro-6-(m-hydroxybenzoyloxy) Phenyl m-Hydroxybenzoate) Inhibits GLUT1-mediated Sugar Transport by Binding Reversibly at the Exofacial Sugar Binding Site. J Biol Chem 291:26762-26772
Sage, Jay M; Cura, Anthony J; Lloyd, Kenneth P et al. (2015) Caffeine inhibits glucose transport by binding at the GLUT1 nucleotide-binding site. Am J Physiol Cell Physiol 308:C827-34
Simpson, Ian A; Ponnuru, Padmavathi; Klinger, Marianne E et al. (2015) A novel model for brain iron uptake: introducing the concept of regulation. J Cereb Blood Flow Metab 35:48-57
Sage, Jay M; Carruthers, Anthony (2014) Human erythrocytes transport dehydroascorbic acid and sugars using the same transporter complex. Am J Physiol Cell Physiol 306:C910-7
De Zutter, Julie K; Levine, Kara B; Deng, Di et al. (2013) Sequence determinants of GLUT1 oligomerization: analysis by homology-scanning mutagenesis. J Biol Chem 288:20734-44
Vollers, Sabrina S; Carruthers, Anthony (2012) Sequence determinants of GLUT1-mediated accelerated-exchange transport: analysis by homology-scanning mutagenesis. J Biol Chem 287:42533-44
Cura, Anthony J; Carruthers, Anthony (2012) Role of monosaccharide transport proteins in carbohydrate assimilation, distribution, metabolism, and homeostasis. Compr Physiol 2:863-914

Showing the most recent 10 out of 34 publications